健脾消浊方配合揿针贴治疗中心性肥胖伴糖耐量受损临床研究OA
Clinical Study on Jianpi Xiaozhuo Prescription Combined with Thumbtack Needle for Central Obesity and Impaired Glucose Tolerance
目的:观察健脾消浊方配合揿针贴对中心性肥胖伴糖耐量受损(IGT)患者糖、脂代谢的影响.方法:选取2022年6月—2024年6月河南中医药大学人民医院收治的86例中心性肥胖伴IGT患者,采用随机数字表法分为对照组和观察组各43例.对照组给予常规运动、饮食指导,观察组在对照组基础上给予健脾消浊方配合揿针贴治疗.2组均持续治疗3个月.比较2组治疗前后腰围、体质量、体质量指数(BMI)、血脂及血糖水平,观察不良反应发生情况.结果:治疗后,观察组腰围、体质量、BMI水平较治疗前降低(P<0.05);且观察组腰围、体质量、BMI水平均低于对照组(P<0.05).治疗后,2组空腹胰岛素(FINS)、空腹血糖(FBG)、餐后2 h胰岛素(2hINS)、餐后2 h血糖(2hPG)水平较治疗前降低(P<0.05);且观察组FINS、FBG、2hINS、2hPG水平均低于对照组(P<0.05).治疗后,观察组高密度脂蛋白胆固醇(HDL-C)水平较治疗前升高,甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)水平较治疗前降低(P<0.05);且观察组HDL-C水平高于对照组,TG、LDL-C、TC水平均低于对照组(P<0.05).2组不良反应发生率比较,差异无统计学意义(P>0.05).结论:健脾消浊方配合揿针贴治疗能够有效促进中心性肥胖伴IGT患者糖、脂代谢恢复正常,改善肥胖状态,安全性高.
Objective:To observe the effect of Jianpi Xiaozhuo Prescription combined with thumbtack needle on glucose and lipid metabolism in patients with central obesity and impaired glucose tolerance(IGT).Methods:A total of 86 patients with central obesity and IGT who were admitted to the People's Hospital of Henan University of Chinese Medicine from June 2022 to June 2024 were selected and divided into the control group and the observation group using the random number table method,with 43 cases in each group.The control group received conventional exercise and dietary guidance,while the observation group received Jianpi Xiaozhuo Prescription combined with thumbtack needle on the basis of the treatment in the control group.Both groups received continuous treatment for three months.Waist circumference,body weight,body mass index(BMI),blood lipid levels,and blood glucose levels were compared between the two groups before and after treatment.The incidence of adverse reactions was observed.Results:After treatment,the observation group showed a reduction in waist circumference,body weight,and BMI level compared with those before treatment(P<0.05);the waist circumference was smaller,and the body weight and BMI level were lower in the observation group than those in the control group(P<0.05).After treatment,levels of fasting insulin(FINS),fasting blood glucose(FBG),2-hour postprandial insulin(2hINS),and 2-hour postprandial blood glucose(2hPG)decreased in both groups compared with those before treatment(P<0.05);the levels of the four indicators in the observation group were lower than those in the control group(P<0.05).After treatment,the high-density lipoprotein cholesterol(HDL-C)level increased,while triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),and total cholesterol(TC)levels decreased in the observation group compared with those before treatment(P<0.05).The HDL-C level in the observation group was higher than that in the control group,while TG,LDL-C,and TC levels were lower than those in the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Jianpi Xiaozhuo Prescription combined with thumbtack needle can effectively promote the normalization of glucose and lipid metabolism and improve the obese state in patients with central obesity and IGT,with higher safety.
于中玲;付利然;陈静;李彦莹;赖耀文;彭书玲;李芝明
河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000河南中医药大学人民医院/郑州人民医院中医科,河南 郑州 450000
医药卫生
中心性肥胖糖耐量受损健脾消浊方揿针贴糖代谢脂代谢
Central obesityImpaired glucose toleranceJianpi Xiaozhuo PrescriptionThumbtack needleGlucose metabolismLipid metabolism
《新中医》 2026 (3)
29-33,5
国家中医临床研究基地科研专项(2021JDZX2089)
评论